- £172.60m
- £166.59m
- £38.44m
Holding(s) in Company
Holding(s) in Company
Diaceutics and Syndax expand Relay partnership
UK's Diaceutics H1 revenue rises, gross margin expands
Brief: Diaceutics H1 Pretax Profit GBP -3.968 Million
Interim Results - six months ended 30 June 2026
Notice of Results & Presentations
Diaceutics and PCC launch NGS Concordance Study
PDMR Shareholding/Share Incentive Plan & TVRs
Brief: Diaceutics Says H1 2026 Revenue Grows 22% At Constant Currency To £17.50 Million
75% ARR Growth Drives Revenue & Profit Visibility
Notice of AGM & Posting of Annual Report
Brief: Diaceutics Says Q1 2026 Performance In Line With Board's Expectations
Final Results
Notice of Results
Holding(s) in Company
PDMR Shareholding/Share Incentive Plan and TVRs
PDMR Shareholding/SIP & Total Voting Rights
PDMR Shareholding/Share Incentive Plan and TVRs